Bio Essence Corporation reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 0.116148 million compared to USD 0.163342 million a year ago. Revenue was USD 0.155695 million compared to USD 0.192052 million a year ago. Net loss was USD 0.314842 million compared to USD 0.199233 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
For the nine months, sales was USD 0.407814 million compared to USD 0.483432 million a year ago. Revenue was USD 0.756598 million compared to USD 0.786602 million a year ago. Net loss was USD 0.778192 million compared to USD 0.596548 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.02 a year ago.